GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Health Issues HCR

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2. Advocate for continuation of ACA CSR subsidy payments.

Contacted: SENATE; Homeland Security, Dept of (DHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); White House Office; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Office of Management & Budget (OMB)

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (support) (H.R.2267/S.1301). Oppose the continuation of Medicaid Disproportionate Share Hospital (DSH) cuts. The Empire State Equity Act (H.R. 2088) - support. Provide comments to CMS on the Medicare IPPS FY 2018 proposed rule, advocate for a delay of proposed rule section dealing with DSH uncompensated care pool. Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose. Oppose legislation that would harm 340B program. Provided comments to CMS on the OPPS final rule addressing payments to off-campus hospital outpatient departments.

Contacted: Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Environmental Protection Agency (EPA); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 1301 (115th), H.R. 2088 (115th), S.Con.Res. 3 (115th), H.R. 2267 (115th), H.R. 1628 (115th)

Budget/Appropriations BUD

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and Better Care Reconciliation Act (Senate) (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again). Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); White House Office; Environmental Protection Agency (EPA); Substance Abuse & Mental Health Services Administration (SAMHSA); Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1628 (115th), S.Con.Res. 3 (115th)

Immigration IMM

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); White House Office; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA)

Pharmacy PHA

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases. Support drug pricing legislation that would promote competition by fast tracking generic drug applications (H.R. 749/S.297). Oppose legislation that would harm the 340B drug discount program for safety net hospitals.

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Homeland Security, Dept of (DHS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; White House Office; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC); SENATE; Office of Management & Budget (OMB)

Bills named: S. 297 (115th), H.R. 749 (115th)